Structural Heart > TAVI Portfolio > ACURATE neo2 > Investigator Initiated Studies



 

1st and largest real-world comparison of ACURATE neo™ self-expanding valve and SAPIEN 3 balloon expandable valve.

STUDY DESIGN: 1:2 propensity-matched multicenter comparison of ACURATE neo (n = 311) and SAPIEN 3 (n = 622)
from three high-volume centers in Germany

60% Risk of PPI icon
-62% Mean Gradient icon
 

 

1st comparison of ACURATE neo self-expanding valve and SAPIEN 3 balloon expandable valve
in patients with small aortic annuli. 

STUDY DESIGN: 1:1 propensity-matched multicenter comparison of ACURATE neo (n = 92) and SAPIEN 3 (n = 92)
from five high-volume centers in Germany.

-62% Mean Gradient icon
-86% Severe PPM icon
 

 

STUDY DESIGN: Analysis of 249 patients ACURATE neo (n=146) and SAPIEN 3 (n=103) treated with TF TAVI using the minimalist approach at Helsinki University Central Hospital to assess the success rate and safety of NDD at 90 days
and 1 year post-implantation.

 

60% next day discharge success icon
9.2% Device Failure, compared to 6.2% SAPIEN icon
60% Risk of PPI icon
 

 

STUDY DESIGN: Analysis of 296 patients with pre-existing complete RBBB ACURATE neo (n=98) and SAPIEN 3 (n=198) including a propensity-matched population of 130 patients: ACURATE neo (n=65) and SAPIEN 3 (n=65)

 

 

 

 

 


 

Outcomes of two next-generation self-expanding TAVI valves in real-world patients. STUDY DESIGN: 1:1 propensity score matched multicentercomparison of ACURATE neo (n = 251) and Evolut PRO (n = 251) from 24 international centers

 

9.2% Device Failure, compared to 6.2% SAPIEN icon
safety composite endpoint

 

 

 


 

STUDY DESIGN: Single-center study from Oxford, Great Britain, evaluating the impact of valve selection on procedural outcomes, length of stay (LoS), and 30-day mortality in 231 patients treated with either
ACURATE neo (n = 143) or Evolut R (n = 88).

 

-86% Severe PPM icon
early discharge icon
 

 
 

Sign Up

Get exclusive product updates, training and educational opportunities, and more.
Top